Use of synthetic prostaglandin E1 (misoprostol) for prevention of aspirin-induced gastroduodenal ulceration in arthritic dogs.J Am Vet Med Assoc. 1993 Jan 15; 202(2):251-6.JA
Abstract
A randomized, double-blind, controlled study was performed with 18 arthritic dogs administered aspirin (25 mg/kg of body weight, PO, q 8 h) and excipient (control group) or aspirin and misoprostol (100 micrograms, PO, q 8 h). Dogs in the misoprostol (n = 10) and control (n = 8) groups were primarily compared by use of sequential gastroduodenoscopy, changes in PCV, and prevalence of clinical signs of gastrointestinal disturbance over a 14-day treatment period. The misoprostol/aspirin-treated group had significantly (P < 0.05) less gastroduodenal hemorrhage and ulceration and a significantly (P < 0.05) lower prevalence of vomiting than did the control group.
MeSH
Pub Type(s)
Clinical Trial
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
8428830
Citation
Murtaugh, R J., et al. "Use of Synthetic Prostaglandin E1 (misoprostol) for Prevention of Aspirin-induced Gastroduodenal Ulceration in Arthritic Dogs." Journal of the American Veterinary Medical Association, vol. 202, no. 2, 1993, pp. 251-6.
Murtaugh RJ, Matz ME, Labato MA, et al. Use of synthetic prostaglandin E1 (misoprostol) for prevention of aspirin-induced gastroduodenal ulceration in arthritic dogs. J Am Vet Med Assoc. 1993;202(2):251-6.
Murtaugh, R. J., Matz, M. E., Labato, M. A., & Boudrieau, R. J. (1993). Use of synthetic prostaglandin E1 (misoprostol) for prevention of aspirin-induced gastroduodenal ulceration in arthritic dogs. Journal of the American Veterinary Medical Association, 202(2), 251-6.
Murtaugh RJ, et al. Use of Synthetic Prostaglandin E1 (misoprostol) for Prevention of Aspirin-induced Gastroduodenal Ulceration in Arthritic Dogs. J Am Vet Med Assoc. 1993 Jan 15;202(2):251-6. PubMed PMID: 8428830.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Use of synthetic prostaglandin E1 (misoprostol) for prevention of aspirin-induced gastroduodenal ulceration in arthritic dogs.
AU - Murtaugh,R J,
AU - Matz,M E,
AU - Labato,M A,
AU - Boudrieau,R J,
PY - 1993/1/15/pubmed
PY - 1993/1/15/medline
PY - 1993/1/15/entrez
SP - 251
EP - 6
JF - Journal of the American Veterinary Medical Association
JO - J Am Vet Med Assoc
VL - 202
IS - 2
N2 - A randomized, double-blind, controlled study was performed with 18 arthritic dogs administered aspirin (25 mg/kg of body weight, PO, q 8 h) and excipient (control group) or aspirin and misoprostol (100 micrograms, PO, q 8 h). Dogs in the misoprostol (n = 10) and control (n = 8) groups were primarily compared by use of sequential gastroduodenoscopy, changes in PCV, and prevalence of clinical signs of gastrointestinal disturbance over a 14-day treatment period. The misoprostol/aspirin-treated group had significantly (P < 0.05) less gastroduodenal hemorrhage and ulceration and a significantly (P < 0.05) lower prevalence of vomiting than did the control group.
SN - 0003-1488
UR - https://www.unboundmedicine.com/medline/citation/8428830/Use_of_synthetic_prostaglandin_E1__misoprostol__for_prevention_of_aspirin_induced_gastroduodenal_ulceration_in_arthritic_dogs_
L2 - https://medlineplus.gov/pepticulcer.html
DB - PRIME
DP - Unbound Medicine
ER -